Olix and Lilly Sign Global Deal for Mash and Cardiometabolic
OliX to Receive Initial Payment and Complete Phase 1 Clinical Trial in Australia OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced a global licensing agreement with Eli...